BackOsmotica Pharmaceuticals Plc Overview

Osmotica Pharmaceuticals Plc Operating Income

Operating Income for OSMT.

Quarterly Operating Income

$-22021000.00
45.6% YoY

As of Jun 30, 2023

Annual Operating Income (TTM)

$-57472000.00
16.4% YoY

Trailing 12 months ending Jun 30, 2023

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)